This compound is an active pharmaceutical ingredient impurity, characterized as a benzimidazole derivative with sulfoxide and pyridine substituents. It is a high-molecular-weight, lipophilic, and non-basic compound containing multiple ether linkages and aromatic rings.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 935260-92-7
Linzagolix
gonadotropin-releasing hormone antagonist
Ceftolozane sulfate
active pharmaceutical ingredient
PCI-32765 (Racemate)
Bruton tyrosine kinase inhibitor
Ibrutinib
active pharmaceutical ingredient
5-Methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
pharmaceutical intermediate
1-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazole
GPEBYGLKBPIFHI-UHFFFAOYSA-N
CC1=C(C=CN=C1CN2C3=CC=CC=C3N=C2S(=O)CC4=NC=CC(=C4C)OCCCOC)OCCCOC